Italy

Italy

Italy

Italy

Clinical Trial Application

Italy Clinical Trial Quote Request

Clinical Trials Quote Request

Mandated Coverage

Yes

Standard Limits

For Medical Device studies limits are:
1.000.0000 €/patient
2.5 to 10.000.000 €/protocol
depending upon the size of the trial

For Drug Studies limits will depend on the number of patients :
5.000.000 €/protocol up to 50 patients
7.500.000 €/protocol from 51 to 200 patients
10.000.000 €/protocol for more than 200 patients

Tail Coverage

For Medical Device Studies:
2 years (up to 5 years potentially available)

For Drug Studies:
=> Successor liability: The Damage (bodily injury) must occur within 24 months after the end of the study
=> Extended reporting period: A Claim must be made by a patient within 36 months after the end of the study

If the study involves gene therapy, cellular therapy, radio-pharmaceuticals or children, carriers are required to issue policies with tail coverage of at least 10 years. For the latter i.e. children, carriers issue 10 years irrespective if the study also involves adults

Data Required to Quote

• Clinical Trial Quote Request
• Protocol and Informed Consent Form in English
• Protocol Title in Italian
• Site List is preferable in Italian, but English is acceptable, inclusive of Full Name(s) of Principal Investigator(s), the Hospital(s)/Site Location(s) Address(es) with Area Code. This information is for the carrier files only. Will not be listed on the policy documents.

Malaysia

Malaysia

Clinical Trial Application

Malaysia Clinical Trial Quote Request

Mandated Coverage

Yes

Standard Limits

Around 2.300.000 MYR/patient
Up to 9.300.000 MYR/protocol
75.000 MYR/each claim

Tail Coverage

1 year

Data Required to Quote

• Clinical Trial Quote Request
• Protocol and Informed Consent Form in English
• Local CRO or Legal Representative details (Contact Person Name, Address, Telephone Number and E-Mail Address)
• No refund for policy cancellation

- Certificate and policy will be issued in the name of the local representative